The Most Significant Dermatology Drug Approvals of 2024
The year 2024 has proven to be a remarkable one for the dermatologic field. Marked by groundbreaking drug approvals and advancements that are transforming patient care and outcomes, these innovative developments are reshaping the future of treatment. With cutting-edge therapies addressing previously unmet needs, these new approvals are not only setting new standards for the […]
JAK Inhibitors Usher in a New Era of Alopecia Areata Management
The alopecia areata (AA) community received life-changing news last June with the U.S. Food and Drug Administration’s (FDA) first-ever approval of targeted medications for the autoimmune disorder that causes unpredictable hair loss. After decades of treatment challenges, patients now have two new oral Janus kinase (JAK) inhibitor drugs with proven efficacy specifically for alopecia areata […]
FDA Approves First Drug to Treat Alopecia Areata
The U.S. Food and Drug Administration (FDA) has approved the first systemic treatment for the distressing autoimmune disease alopecia areata, more commonly referred to as just alopecia. This new drug, developed by Eli Lilly, is called Olumiant (baricitinib) and takes the form of a once-a-day pill. The approval of this drug by the FDA is […]
